Asston Pharmaceuticals IPO Allotment To Take Place Today

Mumbai, 14 July 2025: Asston Pharmaceuticals Limited is likely to do allotment for its IPO today, 14th July.  Asston Pharmaceuticals IPO closed on 11 July. The ₹18.88 crore issue, priced at the upper band of ₹123, drew an exceptional response, receiving bids for over 27.86 crore shares against just 16.06 lakh shares available. With an overall subscription of 173.53 times, it stands out as one of the most sought-after SME IPOs of the year. The company is set to list its shares on the BSE SME platform on 16 July 2025.

How to Check Your IPO Allotment Status Today

Investors can now verify their allotment status through two official portals using simple details such as PAN, application number, or DP/Client ID.

Option 1: Maashitla Securities Pvt Ltd (Registrar)

• Visit: www.maashitla.com
• Navigate to the IPO Allotment Status section
• Select Asston Pharmaceuticals Limited from the dropdown
• Enter your PAN, DP/Client ID, or Application Number
• Click Submit to view the status

Option 2: BSE SME Portal

• Visit: www.bseindia.com/investors/appli_check.aspx
• Select “Equity” and choose Asston Pharmaceuticals Limited
• Enter your application number and PAN
• Click Search to retrieve allotment details

Key Post-Allotment Events and Timeline Investors Should Track

Investors should take note of the following dates to stay updated on refund processing, Demat credit, and listing activities:

• Allotment Finalisation: 14 July 2025
• Refund Initiation: 15 July 2025
• Credit of Shares to Demat: 15 July 2025
• Listing on BSE SME: 16 July 2025

Listing Day Expectations Run High Amid Massive Investor Demand

With staggering interest from all categories-424.47× in the HNI segment, 172.13× from retail investors, and 85.76× by qualified institutional buyers (QIBs)-Asston Pharmaceuticals is poised for a strong market debut. A substantial premium listing is widely anticipated, and investor attention is now focused on the initial price discovery and trading volumes on 16 July.

About the Company: Focused Growth in Pharma and Export Markets

Asston Pharmaceuticals specialises in manufacturing and exporting a diverse portfolio of pharmaceutical and nutraceutical formulations, including tablets, capsules, ointments, and syrups. The company operates from its facility in Ambernath, with production also supported by WHO-GMP certified contract manufacturers. Its key export markets include Africa and emerging regions across Asia, underscoring its strategic global outlook.

Investors and market watchers can expect detailed listing coverage and insights once trading begins.

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations